Pregnancy complications and cardiovascular disease death 50-year follow-up of the child health and development studies pregnancy cohort

Circulation

Volumn 132, Issue 13, 2015, Pages 1234-1242

  Cirillo, Piera M ^a   Cohn, Barbara A ^a  

^a PUBLIC HEALTH INSTITUTE   (United States)

Author keywords

Cardiovascular diseases; Cohort studies; Hypertension; Mortality; Preeclampsia; Pregnancy; Preterm birth

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; EARLY ONSET PREECLAMPSIA; FEMALE; GLUCOSURIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; LATE ONSET PREECLAMPSIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MULTIPLE PREGNANCY; OBSTETRIC DELIVERY; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; THIRD TRIMESTER PREGNANCY; VAGINA BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FOLLOW UP; OBSTETRIC HEMORRHAGE; PREGNANCY COMPLICATION; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; ANEMIA; BLOOD; CAUSE OF DEATH; CLINICAL TRIAL; FORECASTING; GLYCOSURIA; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; MORTALITY; MULTICENTER STUDY; NEWBORN; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SMALL FOR DATE INFANT; UNITED STATES; YOUNG ADULT;

ADULT; ANEMIA; CALIFORNIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; FORECASTING; GLYCOSURIA; HEMOGLOBINS; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; YOUNG ADULT;

EID: 84944144324     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.003901     Document Type: Article

References (50)

1. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325:157-160.
2. Hytten FE, Leitch I. The Physiology of Human Pregnancy. Oxford, England: Blackwell Scientific Publications; 1971.
3. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta- Analysis. Eur J Epidemiol. 2013;28:1-19. doi:10.1007/s10654-013-9762-6.
4. Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N, Lawlor DA. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: The Avon Longitudinal Study of Parents and Children. Circulation. 2012;125:1367-1380. doi:10.1161/CIRCULATIONAHA.111.044784.
5. Skjaerven R, Wilcox AJ, Klungsøyr K, Irgens LM, Vikse BE, Vatten LJ, Lie RT. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ. 2012;345:e7677.
6. Bukowski R, Davis KE, Wilson PW. Delivery of a small for gestational age infant and greater maternal risk of ischemic heart disease. PLoS One. 2012;7:e33047. doi:10.1371/journal.pone.0033047.
7. Hastie CE, Smith GC, Mackay DF, Pell JP. Maternal risk of ischaemic heart disease following elective and spontaneous pre- Term delivery: Retrospective cohort study of 750 350 singleton pregnancies. Int J Epidemiol. 2011;40:914-919. doi:10.1093/ije/dyq270.
8. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents?. Circulation 2010;122:579-584. doi:10.1161/CIRCULATIONAHA.110.943407.
9. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166-171. doi:10.1161/HYPERTENSIONAHA.110.150078.
10. Catov JM, Wu CS, Olsen J, Sutton-Tyrrell K, Li J, Nohr EA. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol. 2010;20:604-609. doi:10.1016/j.annepidem.2010.05.007.
11. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53:944- 951. doi:10.1161/HYPERTENSIONAHA.109.130765.
12. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta- Analyses. Am Heart J. 2008;156:918-930. doi:10.1016/j.ahj.2008.06.042.
13. Berends AL, de Groot CJ, Sijbrands EJ, Sie MP, Benneheij SH, Pal R, Heydanus R, Oostra BA, van Duijn CM, Steegers EA. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension. 2008;51:1034-1041. doi:10.1161/HYPERTENSIONAHA.107.101873.
14. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta- Analysis. BMJ. 2007;335:974. doi:10.1136/bmj.39335.385301.BE.
15. Harskamp RE, Zeeman GG. Preeclampsia: At risk for remote cardiovascular disease. Am J Med Sci. 2007;334:291-295. doi:10.1097/MAJ.0b013e3180a6f094.
16. Garovic VD, Hayman SR. Hypertension in pregnancy: An emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol. 2007;3:613- 622. doi:10.1038/ncpneph0623.
17. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA. 2005;294:2751-2757. doi:10.1001/jama.294.21.2751.
18. Smith GD, Sterne J, Tynelius P, Lawlor DA, Rasmussen F. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology. 2005;16:563-569.
19. Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L, Harlap S. Long- Term mortality after preeclampsia. Epidemiology. 2005;16:206-215.
20. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797-1803. doi:10.1016/S0140-6736(05)67726-4.
21. Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension. 2003;42:39-42. doi:10.1161/01.HYP.0000074428.11168.EE.
22. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323:1213-1217.
23. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129, 290 births. Lancet. 2001;357:2002-2006. doi:10.1016/S0140-6736(00)05112-6.
24. Smith GD, Whitley E, Gissler M, Hemminki E. Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet. 2000;356:2066-2067. doi:10.1016/S0140-6736(00)03406-1.
25. Chesley LC. Recognition of the long- Term sequelae of eclampsia. Am J Obstet Gynecol. 2000;182(1 pt1):249-250.
26. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart. 1997;77:154-158.
27. Rich-Edwards JW, McElrath TF, Karumanchi SA, Seely EW. Breathing life into the lifecourse approach: pregnancy history and cardiovascular disease in women. Hypertension. 2010;56:331-334. doi:10.1161/HYPERTENSIONAHA.110.156810.
28. Magee LA, von Dadelszen P. Pre-eclampsia and increased cardiovascular risk. BMJ. 2007;335:945-946. doi:10.1136/bmj.39337.427500.80.
29. Männistö T, Mendola P, Vääräsmäki M, Järvelin MR, Hartikainen AL, Pouta A, Suvanto E. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127:681-690. doi:10.1161/CIRCULATIONAHA.112.128751.
30. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797-1803. doi:10.1016/S0140-6736(05)67726-4.
31. van den Berg BJ, Christianson RE, Oechsli FW. The California Child Health and Development Studies of the School of Public Health, University of California at Berkeley. Paediatr Perinat Epidemiol. 1988;2:265-282.
32. Christianson RE. Studies on blood pressure during pregnancy. I. Influence of parity and age. Am J Obstet Gynecol. 1976;125:509-513.
33. Wang ET, Cirillo PM, Vittinghoff E, Bibbins-Domingo K, Cohn BA, Cedars MI. Menstrual irregularity and cardiovascular mortality. J Clin Endocrinol Metab. 2011;96:E114-E118. doi:10.1210/jc.2010-1709.
34. Cohn BA, Cirillo PM, Christianson RE. Prenatal DDT exposure and testicular cancer: A nested case-control study. Arch Environ Occup Health. 2010;65:127-134. doi:10.1080/19338241003730887.
35. Cohn BA, Cirillo PM, Christianson RE, van den Berg BJ, Siiteri PK. Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst. 2001;93:1133-1140.
36. Cohn BA, Wolff MS, Cirillo PM, Sholtz RI, Christianson RE, van den Berg BJ, Siiteri PK. Timing of ddt exposure and breast cancer before age 50. Lancet. 2002;13:S197.
37. Whittemore AS, Cirillo PM, Feldman D, Cohn BA. Prostate specific antigen levels in young adulthood predict prostate cancer risk: Results from a cohort of Black and White Americans. J Urol. 2005;174:872-6; discussion 876. doi:10.1097/01.ju.0000169262.18000.8a.
38. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:IX- XIV. doi:10.1081/PRG-100104165.
39. Roberts JM, Pearson G, Cutler J, Lindheimer M; NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension. 2003;41:437-445. doi:10.1161/01.HYP.0000054981.03589.E9.
40. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74: 829-836.
41. Abduljalil K, Furness P, Johnson TN, Rostami-Hodjegan A, Soltani H. Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: A database for parameters required in physiologically based pharmacokinetic modelling. Clin Pharmacokinet. 2012;51:365-396. doi:10.2165/11597440-000000000-00000.
42. Kinoshita T, Itoh M. Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonography: The ratio of visceral fat to subcutaneous fat in the abdomen. Gynecol Obstet Invest. 2006;61:115-118. doi:10.1159/000089456.
43. Vejrazkova D, Vcelak J, Vankova M, Lukasova P, Bradnova O, Halkova T, Kancheva R, Bendlova B. Steroids and insulin resistance in pregnancy. J Steroid Biochem Mol Biol. 2014;139:122-129. doi:10.1016/j.jsbmb.2012.11.007.
44. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, Gonzalez A, Werner JJ, Angenent LT, Knight R, Bäckhed F, Isolauri E, Salminen S, Ley RE. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150:470-480. doi:10.1016/j.cell.2012.07.008.
45. Mor G, Cardenas I. The immune system in pregnancy: A unique complexity. Am J Reprod Immunol. 2010;63:425-433. doi:10.1111/j.1600-0897.2010.00836.x.
46. Williams D. Pregnancy: A stress test for life. Curr Opin Obstet Gynecol. 2003;15:465-471. doi:10.1097/01.gco.0000103846.69273.ba.
47. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 2004;175:189-202. doi:10.1016/j.atherosclerosis.2004.01.038.
48. Stephansson O, Dickman PW, Johansson A, Cnattingius S. Maternal hemoglobin concentration during pregnancy and risk of stillbirth. JAMA. 2000;284:2611-2617.
49. Ferrara A, Hedderson MM, Quesenberry CP, Selby JV. Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds. Diabetes Care. 2002;25:1625-1630.
50. Intapad S, Alexander BT. Future cardiovascular risk: interpreting the importance of increased blood pressure during pregnancy. Circulation. 2013;127:668-669. doi:10.1161/CIRCULATIONAHA.112.000677.